Emily Erbelding
Emily Erbelding is a prominent medical researcher and physician specializing in infectious diseases. She is currently the Director of the Division of Microbiology and Infectious Diseases (DMID) at the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH).
Early Life and Education[edit | edit source]
Erbelding was born and raised in United States. She completed her undergraduate studies at the University of Notre Dame, where she majored in biology. She then went on to earn her medical degree from the Johns Hopkins University School of Medicine. Following her graduation, she completed her residency in internal medicine at the Johns Hopkins Hospital.
Career[edit | edit source]
After completing her residency, Erbelding joined the faculty of the Johns Hopkins University School of Medicine, where she served as an associate professor in the Division of Infectious Diseases. During her tenure at Johns Hopkins, she conducted extensive research on HIV/AIDS, hepatitis C, and other infectious diseases.
In 2018, Erbelding was appointed as the Director of the DMID at the NIAID. In this role, she oversees the institute's research on microbiology and infectious diseases, including the development of vaccines, antimicrobials, and diagnostics.
Research and Contributions[edit | edit source]
Erbelding's research has significantly contributed to the understanding and treatment of infectious diseases. She has published numerous peer-reviewed articles in prestigious medical journals, and her work has been widely recognized by the medical community.
One of her most notable contributions is her research on HIV/AIDS. She has conducted several studies on the prevention and treatment of HIV/AIDS, and her findings have played a crucial role in the development of effective therapies for the disease.
Awards and Recognition[edit | edit source]
Erbelding has received numerous awards and recognition for her contributions to the field of infectious diseases. She is a member of several professional organizations, including the Infectious Diseases Society of America and the American Society for Microbiology.
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
